Τόμος 3 (1989) – Τεύχος 1 – Άρθρο 2 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 3 (1989) – Issue 1 – Article 2 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Laboratory of Pharmaceutical Chemistry, University of Patras, Greece

pharmakonpress[at]pharmakonpress[.]gr

2.         Kikuth, W., Gonnert, R.: Experimental studies on the therapy of schistosomiasis. Ann. Trop. Med. Parasitoi 42: 256 (1948)

3.         Archer, S.: The chemotherapy of schistosomiasis. Ann. Rev. Pharmacol. Toxicol. 25: 485 (1895)

4.         Rosi, D., Peruzzoti, G., Dennis, E.W., Berberian, D.A., Freele, H., Archer, S.: A new active metabolite of “Miracil D”. Nature 208: 1005 (1965)

5.         Rosi, D., Peruzzoti, G., Dennis, E.W., Berberian, D.A., Freele, H., Tullar, B.F., Archer, S.: Hycanthone, a new active metabolite of lucanthone. J. Med. Chem. 10: 867 (1967)

6.         Pica-Mattoccia, L, Lelli, A., Cioli, D.: Sex and drugs in Schistosoma mansoni. J. Parasitoi. 68: 347 (1982)

7.         Yarinsky, A., Hernandez, P., Ferrari, R.A., Freele, H.W.: Effects of hycanthone against two strains of S. japonicum in mice. Jap. J. Parasitoi. 21: 101 (1972)

8.         Hirschberg, E.: Thioxanthenones: Miracil D and hycanthone. In: Mechanism of Action of Antimicrobial and Antitumor Agents (J.W. Corcoran and F.E. Hahn, eds), p. 274. Springer-Verlag, Berlin, Heidelberg, 1975

9.         Hartman, P.E., Levine, E., Hartman, Z., Berger, H.: Hycanthone a frameshift mutagen. Science 172: 1058 (1971)

10.       Moore, J.A.: Teratogenicity of hycanthone in mice. Nature 107: 239 (1972)

11.       Sieber, S.M., Adamson, R.H.: Evaluation of the teratogenic activity of hycanthone in mice and rabbits. J. Toxicol. Environ. Health 1: 309 (1975)

12.       Haese, W.H., Smith, D.L., Bueding, E.: Hycanthone-in- duced hepatic changes in mice infected with Schistosoma mansoni. J. Pharmacol. Exp. Ther. 186: 430 (1973)

13.       Yarinsky, A., Drobeck, H.P., Freele, H., Wiland, J., Gumaer, K.L.: An 18-month study of parasitologenic and tumorigenic effects of hycanthone in Schistosoma mansoni-infected and non-infected mice. Toxicol. Appi Pharmacol. 27: 169 (1974)

14.       Neidle, S.: Nucleic acid binding drugs: The structure of Miracil D, a DNA binding drug. Biochim. Biophys. Acta 454: 207 (1976)

15.       Mauss, H.: Ober basisch substituierte Xanthon- und Thioxanthon- Abkommlinge; Miracil, ein neues Chemotherapeuticum. Chem. Ber. 81: 19 (1948)

16.       Archer, S., Suter, C.M.: The preparation of some 1-alkylamino- and dialkylaminoalkylaminothioxanthones. J. Am. Chem. Soc. 74: 4296 (1952)

17.       Cioli, D., Knopf, P.M.: A study of the mode of action of hycanthone against Schistosoma mansoni in vivo and in vitro. Am. J. Trop. Med. Hyg. 29: 220 (1980)

18.       Gonnert, R.: The structure-activity relationship in several schistosomicidal compounds. Bull. Wld Hlth Org. 25: 702 (1961)

19.       Yarinsky, A., Hernandez, P., Dennis, E.W.: The uptake of tritiated hycanthone by male and female Schistosoma mansoni worms and distribution of the drug in plasma and whole blood of mice following a single intramuscular injection. Bull. Wld Hlth Org. 42: 445 (1970)

20.       Hernandez, P., Dennis, E.W., Farah, A.: Metabolism of the schistosomicidal agent hycanthone by rats and rhesus monkeys. Bull. Wld Hlth Org. 45: 27 (1971)

21.       Tomosky-Sykes, T.K., Budeing, E.: Effects of hycanthone on neuromuscular systems of Schistosoma mansoni. J. Parasitol. 63: 259 (1977)

22.       Hillman, G.R„ Senft, A.W.: Anticholinergic properties of the antischistosomal drug hycanthone. Am. J. Trop. Med. Hyg. 24: 827 (1975)

23.       Hillman, G.R., Gibler, W.B.: Acetylcholine receptors in Schistosoma mansoni: Visualization and blockade by hycanthone. Biochem. Pharmacol. -24: 1911 (1975)

24.       Senft, A.W., Hillman, G.R.: Hycanthone effects on schistosomes and its likely mode of action. In; Biochemistry of Parasites and Host-parasite Relationships (H. Van den Bossche, ed.), p. 619, Elsevier/North-Holland, Amsterdam, 1976

25.       Pica-Mattpccia, L., Cioli, D.: Lack of correlation between schistosomicidal and anticholinergic properties of hycanthone and related drugs. J. Parasitol. 72: 531 (1976)

26.       Kim, R.A., Lukacs, J., Tanaka, R.D., Macinnis, A.J.: Effects of hycanthone and praziquantel on monoamine oxidase and cholinesterases in Schistosoma mansoni. J. Parasitol. 67: 20 (1981)

27.       Cioli, D., Pica-Mattoccia, L., Rosenberg, S., Archer, S.: Evidence for the mode of antischistosomal action of hycanthone. Life Sci. 37: 161 (1985)

28.       Pica-Mattoccia, L., Cioli, D., Archer, S.: Schistosomicides and DNA functioning. Biochem. Soc. Trans. 15: 70 (1987)

29.       Cioti, D., Pica-Mattoccia, L.: Genetic analysis of hycanthone-resistance in Schistosoma mansoni. Am. J. Trop. Med. Hyg. 33: 80 (1984)

30.       Carchman, R., Hirschberg, E., Weinstein, B.I., Miracil D.: Effect on the viscocity of DNA. Biochem. Biophys. Acta 179: 158 (1969)

31.       Hirschberg, E., Weinstein, I.B., Gersten, N., Marner, E., Finkelstein, T., Carchman, R.: Structure-activity studies on the mechanism of action of Miracil D. Cancer Res. 28: 60 (1968)

32.       Weinstein, I B. Chernoff, R., Finkelstein, I., Hirschberg. E.: An inhibitor of ribonucleic acid synthesis in Bacillus Subtilis. Mot. Pharmacol. 1: 297 (1965)

33.       Weinstein, I.B., Carchman, R. (Marner, E., Hirschberg, E., Miracil D.: Effects on nucleic acid synthesis, protein synthesis and enzyme induction in Escherichia coli. Biochim. Biophys. Acta 142: 440 (1967)

34.       Bases, R., Mendez, F.: Reversible inhibition of ribosomal RNA synthesis in HeLa by lucanthone with continued synthesis of DNA-like RNA. J. Cell. Physiol. 74: 283 (1969)

35.       Wittner, M., Tanowitz, H., Rosenbaum, M.: Studies with the schistosomicide hycanthone. Inhibition of macromolecular synthesis and its .reversal. Exp. Mot. Pathol. 14: 124 (1971)

36.       Obe, G.: Distribution of miracil-D-induced achromatic lesions and chromatid breaks on the chromosomes of human leukocytes. Z. Naturforsch. 25: 115 (1970)

37.       Simoni, I.C., Mello, M.L.S.: Investigation of hycanthone binding to DNA in chromatin with different supra-organization, composition and function. Acta Histochem. 79: 97 (1986)

38.       Waring, M.: Binding of drugs to supercoiled circular DNA; Evidence for and against intercalation. In: Progress in Molecular and Sucellular Biology (F.E. Hahn, ed.), Vol. 2, p. 216, Springer-Verlag, New York, 1971

39.       Sarma, M.H., Mitra, C.K., Sarma, R.H., Miller, K.J., Archer, S.: Interaction between double stranded poly(dA- df).poly(dA-dT) and lucanthone. Biochem. Biophys. Res. Comm. 94: 1285 (1980)

40.       Hartman, P.E., Hulbert, P.B.: Genetic activity spectra of some antischistosomal compounds with particular emphasis of thioxanthenones and benzothiopyranoindazoles. J. Toxicol. Environ. Health 2: 243 (1975)

41.       Hirschberg, E., Gellhorn, A., Murray M.R., Elslager, E.F.: Effects of Miracil D, Amodiaquin and a series of other 10-thiaxanthenones and 4-aminoquinolines| against a variety of experimental tumors in vitro and in vivo. J. Natl. Cancer Inst. 22: 567 (1959)

42.       Blanz, E.J. Jr., French, F.A.: A systematic investigation of thiaxanthen-9-ones and analogs as potential antitumor agents. J. Med, Chem. 6: 185 (1963)

43.       Reztsova, V.V., Goryukhina, T.A., Seits, I.F.: Molecular mechanism of the antitumor effects of lucanthone. Vopr. Onkol. 24: 91 (1978)

44.       Oswald, H., Youssef, M.: Overadditive synergism between the intercalators mitoxanthrone and lucanthone in advanced L1210 and P388 leukemia. J. Cancer Res. Clin. Oncol. 111: 137 (1986)

45.       Hischberg, E., Brindle, S.D., Semente, G.: Development and properties of mouse leukemia LI 210 resistant to Miracil D. Cancer Res. 24: 1733 (1964)

46.       Hirschberg, E.: In: Antibiotics (J.W. Corcoran and F.E. Hahn, eds). Vol. Ill, p. 274, Springer-Verlag, Berlin and Heidelberg, 1974

47.       Archer, S., Miller, K.J., Rej, R., Periana, C., Fricker, L: Ring-hydroxylated analogues of lucanthone as antitumor agents. J. Med. Chem. 25: 220 (1982)

48.       Archer, S., Zayed, A.-H., Rej, R., Rugino, T.A.: Analogues of hycanthone and lucanthone as antitumor agents. J. Med. Chem. 26: 1240 (1983)

49.       Archer, S., Pica-Mattoccia, L., Cioli, D., Seyed-Mozaffari, A., Zayed, A.-H.: Preparation and antischistosomal and antitumor activity of hycanthone and some of its congeners. Evidence for the mode of action of hycanthone. J. Med Chem. 31: 254 (1988)

50.       Clive, D., Flamm, W.G., Machesko, M.R.: Mutat. Res. 14: 262 (1972)

51.       Kramers, P.G.N.: Mutagenicity of hycanthone in Drosophila: Additional results and a comparison with some analogs. Mutat. Res. 82: 111 (1981)

52.       Hulbert, P.B., Bueding, E. (Hartman, P.E.: Hycanthone analogs: dissociation of mutagenic effects from antischistosomal effects. Science 186: 647 (1974)

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr